{"id":"W3082576563","doi":"10.1097/qai.0000000000002466","title":"Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials","year":2020,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Torii Pharmaceutical; ViiV Healthcare; Gilead Sciences; GlaxoSmithKline","keywords":"Rilpivirine; Medicine; Fluid-attenuated inversion recovery; Atlas (anatomy); Clinical trial; Antiretroviral therapy; Human immunodeficiency virus (HIV); Internal medicine; Medical physics; Virology; Radiology; Viral load; Magnetic resonance imaging","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02612774,0.002118699,0.006780731,0.001547429,0.0003869833,0.002445931,0.001057042,0.001683252,0.003702052],"category_scores_gemma":[0.01975317,0.0008111069,0.0186718,0.001739953,0.0005263895,0.001419691,0.001263322,0.001632724,0.0004938022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001032834,"about_ca_system_score_gemma":0.001618386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001011286,"about_ca_topic_score_gemma":0.003067036,"domain_scores_codex":[0.981169,0.0141593,0.00145343,0.001393169,0.001292935,0.0005322902],"domain_scores_gemma":[0.9881139,0.005120542,0.004172991,0.001269078,0.000816839,0.0005065025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4554655,0.0003794107,0.01735369,0.008959367,0.4778904,0.0001546716,0.0001211206,0.002237649,0.002318314,0.0001485291,0.003307528,0.03166381],"study_design_scores_gemma":[0.2224748,0.0262392,0.1210771,0.001964642,0.6140516,0.0004661211,0.0001856078,0.003478167,0.001686374,0.001137879,0.006987761,0.0002506562],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6832382,0.2737467,0.009559239,0.001690722,0.0007278996,0.00578866,0.01884102,0.0009071163,0.005500448],"genre_scores_gemma":[0.9753687,0.01055696,0.002986787,0.001162369,0.0003497919,0.003134024,0.005240418,0.0001392393,0.001061701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02612774,"threshold_uncertainty_score":0.1381783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04886990321091243,"score_gpt":0.3219848877726683,"score_spread":0.2731149845617558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}